Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2023 Nice Insight Reports
Cell & Gene Therapy: 2023 Market Analysis, CDMO Pricing and Benchmarking
Monoclonal Antibody & Recombinant Protein: 2023 Market Analysis, CDMO Pricing and Benchmarking
mRNA Vaccines & Therapeutics: 2023 Market Analysis, CDMO Pricing and Benchmarking
Sterile Drug Product: 2023 Market Analysis, CDMO Pricing and Benchmarking
Active Pharmaceutical Ingredients: 2023 Market Analysis, CDMO Pricing and Benchmarking
Antibody Drug Conjugates: 2023 Market Analysis, CDMO Pricing and Benchmarking
Contract Research Organizations: 2023 Market Analysis, Pricing and Benchmarking
Oral Solid Dosage: 2023 Market Analysis, CDMO Pricing and Benchmarking
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Alcami
33 Articles Available
1
2
Can't find what you're looking for? Try our
advanced search
.
New cGMP Facility
Alcami Builds cGMP Biostorage Facility in North Carolina
PR-M12-22-01
Facility Expansion
Alcami Expands Biopharma Storage at Masy BioServices
PR-M03-22-15
Leadership
Q: What’s the key to being a leader in the industry?
PAO-03-022-RT-02
Milestones
Q: What important company milestone do you anticipate reaching in 2022?
PAO-03-022-RT-01
Therapeutic Progress
Q: For what therapeutic area do you think we will see the greatest progress in the coming years?
PAO-12-21-RT-02
FDA Approval
Alcami Helps Medicines Development for Global Health Secure FDA Approval of Moxidectin for River Blindness
PR-M10-18-NI-095
Investment
Aligning with Sponsors for Strategic Growth
PAP-Q3-18-CL-014
Workforce
Grant Will Fund Workforce Development Program for Biopharma Industry
PAO-M09-18-NI-001
Commercial Supply
Alcami's Extended Workbench Supports Commercial Supply of Flexion Therapeutics's ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)
PR-M06-18-NI-047
Acquisition
Alcami to Become Industry Leading Platform CDMO Following Acquisition by Madison Dearborn Partners
PR-M06-18-NI-021
Announcement
Alcami St. Louis Facility to be Honored by Missouri House of Representatives and City of St. Louis
PR-M05-18-NI-032
Donation
Alcami Donation to Outfit TROSA Medical Department
PR-M03-18-NI-065
Strategic Collaboration
Driving Change in the Pharma Industry and Biotech One Relationship at a Time
PAP-Q1-18-CL-004
Growth
Fueled by Growth, Alcami Unveils New Sales Office in Cambridge, MA
PR-M02-18-NI-63
Analytical Testing
Analytical Testing — Contractors Take on the Challenge of Complex Molecules
PAO-M01-18-NI-024
Partnership
Alcami to Produce Clinical Supplies of Darinaparsin for Solasia
PAO-M11-17-NI-042
CDMO
Alcami to Manufacture Darinaparsin
PAO-M11-17-NI-016
API
Right-First-Time Innovation Approach Drives Continual Investment
PAP-Q4-17-CL-003
Facility
Alcami Announces Grand Opening of St. Louis, Missouri Facility In Cortex Innovation Community
PR-M09-17-NI-003
Expansion
Alcami Establishes New Center of Excellence
PAO-M09-17-NI-018
Abuse Deterrence
Fighting Prescription Drug Abuse with Demonstrated Abuse-Deterrent Formulations
PAP-Q3-17-CL-003
Serialization
Alcami on the Road to BIO: Creating Differentiated Value For Biotechs
PTV-M06-17-CL-009
Regulatory
Implications of Serialization for the U.S. Pharma Industry
PAP-Q2-17-CL-001
Partnering for Formulation Development
PTV-M11-16-AP-001
1
2
»
